YZi Labs again criticizes CEA Industries for adopting a "poison pill" plan and defensive charter revisions.

YZi Labs published an article on the X platform, again criticizing CEA Industries (BNC) for restricting shareholders' right to written consent through the introduction of a poison pill plan and amendments to its bylaws. YZi Labs argues that this move is intended to strengthen the board's power rather than protect shareholder interests. YZi Labs also refuted BNC's claim that it had never considered alternative tokens, pointing out that BNC CEO David Namdar explicitly stated at an industry conference in November 2025 that BNC had considered using other crypto assets, such as Solana. YZi Labs called on the board to refrain from further manipulation and ensure a fair and transparent process for nominating and electing directors at the 2025 shareholder meeting. YZi Labs has filed a preliminary consent statement with the U.S. Securities and Exchange Commission, seeking to expand the size of BNC's board and elect its nominated directors.